A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for Non-Muscle Invasive Bladder Neoplasms
13 locations incl. Birmingham
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07309445·Recruiting·Listed Dec 2025